Mr. Moore has served as Chief Business Officer since January 2013. He joined Tranzyme in 2011 as Vice President, Commercial Operations and his responsibilities were increased in January 2012 to include the oversight of Business Development. Before joining Tranzyme, Mr. Moore was employed by Ortho-McNeil Janssen, a Johnson & Johnson company where he served as Group Director responsible for the commercialization of new pain therapeutics. He has experience in New Business Development, Disease Management / Market Development Campaigns, Launch Readiness and unique experience in developing Hospital and Payer Value Platforms. In addition, Mr. Moore held numerous positions of increasing responsibility in sales, sales management, training, market research, managed care account management and payer marketing. Mr. Moore received his MBA in marketing from Lehigh University and a degree in Health Policy from Thomas Jefferson University.